TY  - GEN
AU  - Wang,Jing
AU  - Xia,Ting-Yi
AU  - Wang,Ying-Jie
AU  - Li,Hong-Qi
AU  - Li,Ping
AU  - Wang,Ji-Dong
AU  - Chang,Dong-Shu
AU  - Liu,Liy-Yuan
AU  - Di,Yu-Peng
AU  - Wang,Xuan
AU  - Wu,Wei-Zhang
TI  - Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
SN  - 1879-355X
PY  - 2011///1207
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - methods
KW  - Disease Progression
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Follow-Up Studies
KW  - Gefitinib
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prospective Studies
KW  - Quinazolines
KW  - Radiation Injuries
KW  - pathology
KW  - Radiotherapy Dosage
KW  - Tumor Burden
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ijrobp.2010.12.035
ER  -